Search results | Galderma

You searched for: «sculptra»

IMCAS 2026: Galderma showcases the latest scientific advances behind the industry’s broadest injectable aesthetics portfolio

At IMCAS 2026, Galderma will present findings supporting Sculptra’s^® regenerative properties and benefits on the body, including improving cellulite appearance, firmness, lift, projection, and contouring following its European Union (EU) Medical Device Regulation (MDR) certification, expanding its use to four body areas^1-7
Multiple studies will reinforce

IMCAS 2023: Galderma to share latest data demonstrating high aesthetic improvement and patient satisfaction across its innovative portfolio

Galderma will share exciting results from the Sculptra^® Cheek Wrinkle study showing the long-lasting effectiveness and safety of Sculptra, as well as high aesthetic improvement and patient satisfaction over two years[i]

The company will also present 10 research poster

Sculptra

AMWC 2026: Galderma showcases category‑leading innovation with a comprehensive portfolio and holistic, future‑focused aesthetic strategies

Galderma will present nine posters spanning its full aesthetics portfolio at AMWC 2026, highlighting the regenerative benefits of Sculptra^®, the long-lasting efficacy of Restylane^®, and the advanced clinical performance of Relfydess^®(RelabotulinumtoxinA)^1-9
The data reinforce Galderma’s future-focused approach to innovation, addres

ASDS 2025: Compelling new data on Restylane, Sculptra and Relfydess highlight Galderma’s innovative Injectable Aesthetics portfolio and pipeline

At ASDS 2025, Galderma unveiled pivotal new data from its range of pioneering Restylane^® hyaluronic acid (HA) injectables, highlighting its versatility in improving the chin profile with Restylane Lyft™, temple volume with investigational Restylane Contour™* and skin quality in the décolletage (neckline) with investigational R